Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

Financials ($)
Sales 2015 9 651 M
EBIT 2015 2 772 M
Net income 2015 2 013 M
Debt 2015 6 148 M
Yield 2015 -
Sales 2016 10 654 M
EBIT 2016 3 199 M
Net income 2016 2 371 M
Debt 2016 4 443 M
Yield 2016 -
P/E ratio 2015 23,68
P/E ratio 2016 12,91
EV / Sales 2015 3,23x
EV / Sales 2016 2,77x
Capitalization 25 020 M
More Financials
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through the following businesses: Generic Products, Rx Products, Active Pharmaceutical Ingredients, and Access... 
02/25Earnings Release
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
07:58a MYLAN NV : Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for 's Over-t..
07:31a MYLAN NV : Launches Generic FazaClo® Orally Disintegrating Tablets
11/23DJPfizer Inversion Puts Pressure on U.S. Lawmakers to Revamp Tax Rules -- Updat..
11/23DJPfizer Inversion Puts Pressure on U.S. Lawmakers to Revamp Tax Rules
11/23 MYLAN NV : Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase..
11/20 MYLAN NV : U.S. District Court Denies Perrigo's Motion for Preliminary Injunctio..
11/20 MYLAN NV : Completes Acquisition of Certain Businesses from Famy Care to Create ..
11/20DJPfizer Girds For Fight On Tax-Saving Foreign Deal
More news
Sector news : Pharmaceuticals - NEC
09:25p ONO PHARMACEUTICAL : New Long-Term Data on Opdivo and the Opdivo + Yervoy Regime..
09:25p ONO PHARMACEUTICAL : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivo..
09:06pDJFDA PANEL : BioMarin Muscular Dystrophy Not Effective
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/02 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
03/02 Mylan Q4 revenues up 15%, Specialty up 38%
03/02 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
03/02 Mylan EPS in-line, beats on revenue
03/01 Notable earnings after Monday?s close
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends MYLAN INC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions